Research compound reference
Informational pages on peptides and compounds commonly encountered in metabolic, recovery, and longevity research. Each entry covers mechanism of action, published research context, and regulatory status. None of this content constitutes medical advice.
Research use only. The compounds discussed here include approved medications, investigational drugs, and research peptides. Material sold as a research chemical is intended strictly for laboratory use and is not cleared for human administration. This page is not medical advice. Consult a qualified healthcare provider about any treatment decisions.
GLP-1 & Metabolic
Semaglutide
Long-acting GLP-1 receptor agonist originally developed by Novo Nordisk.
Also: GLP-1, Ozempic, Wegovy
Tirzepatide
First-in-class dual GIP and GLP-1 receptor agonist developed by Eli Lilly.
Also: GLP-1/GIP, Mounjaro, Zepbound
Retatrutide
Investigational triple agonist of GLP-1, GIP, and glucagon receptors.
Also: LY3437943, GGG tri-agonist
Cagrilintide
Long-acting amylin receptor analog in clinical development by Novo Nordisk.
Also: AM833, long-acting amylin analog
CagriSema
Investigational combination of a long-acting amylin analog and semaglutide.
Also: Cagrilintide and semaglutide, Cagri/Sema
Healing & Recovery
BPC-157
Synthetic 15-amino-acid peptide derived from a fragment of a gastric juice protein.
Also: Body protection compound 157, Pentadecapeptide BPC
TB-500
Synthetic peptide related to the active region of thymosin beta-4.
Also: Thymosin beta-4 fragment, TB4 fragment 17-23
GHK-Cu
Naturally occurring copper-binding tripeptide found in human plasma.
Also: Copper tripeptide-1, Glycyl-L-histidyl-L-lysine copper
Growth Hormone Axis
Ipamorelin
Selective growth hormone secretagogue that acts at the ghrelin receptor.
Also: NNC 26-0161
Tesamorelin
Stabilized growth hormone-releasing hormone analog approved for HIV lipodystrophy.
Also: Egrifta, TH9507
IGF-1 LR3
Engineered insulin-like growth factor 1 variant with extended half-life.
Also: Long R3 IGF-1, Long Arg3 IGF-1
CJC-1295
Long-acting GHRH analog engineered with a reactive maleimide group that binds serum albumin.
Also: CJC-1295 with DAC, DAC:GRF
Sermorelin
Synthetic 29 amino acid fragment of human growth hormone-releasing hormone, once FDA-approved for pediatric GH deficiency.
Also: GHRH(1-29), Geref, Sermorelin acetate
AOD-9604
Synthetic 16 amino acid fragment of human growth hormone (positions 176-191), studied as a selective lipolytic agent.
Also: HGH Fragment 176-191, Anti-Obesity Drug 9604
Immune & Longevity
Thymosin Alpha-1
28 amino acid peptide studied extensively as an immune modulator.
Also: TA-1, Tα1, Zadaxin
MOTS-c
16 amino acid peptide encoded within the mitochondrial genome.
Also: Mitochondrial open reading frame of the twelve S rRNA-c
Epithalon
Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal gland protein epithalamin, studied in longevity and aging research.
Also: Epitalon, AEDG peptide, Epithalamin tetrapeptide
NAD+
Coenzyme central to cellular energy metabolism, present in every living cell and required for sirtuin and PARP enzyme function.
Also: Nicotinamide adenine dinucleotide, NAD, Coenzyme I
Melanocortin
Research Support
*These statements have not been evaluated by the Food and Drug Administration. The compounds discussed on this site are not intended to diagnose, treat, cure, or prevent any disease. Content is for educational and research purposes only and is not a substitute for professional medical advice. Material sold by third parties as research chemicals is not cleared for human administration. Always consult your healthcare provider before starting any medication or treatment regimen.